TGFB1 and head and neck squamous cell carcinoma: In the HNSCC literature, it is mainly a high level of SMAD 6 protein and a low level of SMAD 2 protein that have been cited to correlate with better patient survival, with SMAD 6 potentially blocking the oncogenic effects of TGFβ [45].